Literature DB >> 993776

Mechanisms of resistance to fusidic acid in Staphylococcus aureus.

I Chopra.   

Abstract

The biochemical mechanisms of resistance to fusidic acid in Staphylococcus aureus were investigated. Organisms possessing plasmid genes for resistance showed a high basal level of resistance, but could be induced to higher levels after pre-incubation with fusidic acid. This induction occurred rapidly and probably did not depend on gene dosage effects. Mutants resistant to fusidic acid, obtained from plasmid-negative cultures, expressed resistance constitutively. Protein synthesis in cell-free extracts from staphylococci with plasmid-mediated resistance to fusidic acid was as sensitive to fusidic acid as was synthesis in preparations from sensitive organisms; whereas protein synthesis in preparations from a spontaneous fusidic acid resistant mutant was resistant to the antibiotic. None of the resistant strains caused detectable inactivation of fusidic acid and no new derivative of fusidic acid was found in culture extracts of plasmid-possessing organisms grown in the presence of radioactive antibiotic. Expression of plasmid-mediated resistance to fusidic acid was associated with a decrease in the molar ratio of phosphatidylglycerol to lysylphosphatidylglycerol, but the cardiolipin content remained constant.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993776     DOI: 10.1099/00221287-96-2-229

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  19 in total

Review 1.  Molecular mechanisms of drug resistance.

Authors:  J D Hayes; C R Wolf
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

Review 2.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

3.  Novel mechanism for plasmid-mediated erythromycin resistance by pNE24 from Staphylococcus epidermidis.

Authors:  B C Lampson; W von David; J T Parisi
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

4.  Topical Fucidin.

Authors:  S Dealler; A K Fraser
Journal:  J R Coll Gen Pract       Date:  1986-03

5.  Nasal carriage of sodium fusidate resistant Staphylococcus aureus.

Authors:  S Dealler
Journal:  J R Coll Gen Pract       Date:  1988-04

6.  Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.

Authors:  Silke Besier; Albrecht Ludwig; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

7.  A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.

Authors:  Alexander J O'Neill; Anders R Larsen; Anne S Henriksen; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus.

Authors:  Jonas Lannergård; Tobias Norström; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

9.  Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.

Authors:  Tobias Norström; Jonas Lannergård; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2007-10-08       Impact factor: 5.191

10.  Characterization of Staphylococcus aureus plasmids introduced by transformation into Bacillus subtilis.

Authors:  T J Gryczan; S Contente; D Dubnau
Journal:  J Bacteriol       Date:  1978-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.